Media: Hong Kong-listed Brii expects to launch COVID-19 drug as early as January - SCMP
28/12/2021 05:15
-- Source link: https://bit.ly/3evEFLC
-- Note: Reuters has not verified this story and does not
vouch for its accuracy
((Bengaluru newsroom, globalnewsmonitoring@thomsonreuters.com))
Recent news on Brii Biosciences
See all newsBrief: BRII Biosciences Discloses Launch Of BRISC, An SIRNA Therapeutics Discovery Platform
China's Brii Biosciences interim net loss narrows on lower R&D expenses
Brief: Brii Biosciences Announces Share Buy-Back Programme No More Than HK$60 Million
Brief: Brii Biosciences Says Arbitration Between Brii And Vir Remains In Early Stages With No Resolution
Brief: Brii Biosciences Submits Demand For Arbitration Against VIR